文献速递性腺与生殖内分泌肥胖与代谢综合征

多囊卵巢综合征体征与代谢综合征在绝经前西班牙裔/拉丁裔女性中的关联:HCHS/SOL研究

Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该横断面分析纳入1427名24至44岁西班牙裔/拉丁裔绝经前女性,评估多囊卵巢综合征(PCOS)体征与代谢综合征(MetS)的关联。月经周期大于35天或不规则、自报PCOS及任一PCOS体征与MetS风险升高相关,而口服避孕药调节月经或痤疮与MetS无关联;调整BMI后仅自报PCOS的关联减弱。

要点

  • 月经周期大于35天或不规则者MetS风险升高(OR 1.63;95%CI 1.07-2.49)。
  • 自报PCOS者MetS风险升高(OR 2.49;95%CI 1.38-4.50)。
  • 任一PCOS体征与MetS相关(OR 1.58;95%CI 1.10-2.26)。

核心结论

  • 在西班牙裔/拉丁裔女性中,月经周期不规则、自报PCOS及任一PCOS体征与代谢综合征相关,可能提示代谢疾病风险。

研究设计与样本

  • 横断面分析纳入来自西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)的1427名24至44岁绝经前女性。

主要发现

  • 平均年龄34岁,30%报告任一PCOS体征。
  • 月经周期大于35天或不规则者相比周期24至35天者,MetS的OR为1.63(95%CI 1.07-2.49)。
  • 自报PCOS者相比无PCOS者,MetS的OR为2.49(95%CI 1.38-4.50)。
  • 任一PCOS体征者相比无任何体征者,MetS的OR为1.58(95%CI 1.10-2.26)。
  • 口服避孕药调节月经或痤疮与MetS无关联(OR 1.1;95%CI 0.6-1.8)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS), a condition of androgen excess in women, is associated with cardiometabolic risk factors; however, this association is not fully characterized in a population-based sample of premenopausal women and high-risk groups such as Hispanics/Latinas. OBJECTIVE: We examined the association of PCOS signs and metabolic syndrome (MetS) in premenopausal Hispanic/Latina women. METHODS: This cross-sectional analysis includes 1427 women age 24 to 44 years from the Hispanic Community Health Study/Study of Latinos. PCOS signs included menstrual cycle greater than 35 days or irregular, self-reported PCOS, and oral contraceptive use to regulate periods or acne, and a composite of 1 or more PCOS signs. We calculated odds ratios (OR) and 95% CI for MetS, accounting for sociodemographic factors and the complex survey design; an additional model included body mass index (BMI). RESULTS: The mean age was 34 years and 30% reported any PCOS sign. The odds of MetS were higher in women reporting cycles greater than 35 days or irregular (OR 1.63; CI: 1.07-2.49) vs cycles 24 to 35 days, self-reported PCOS (OR 2.49; CI: 1.38-4.50) vs no PCOS, and any PCOS sign (OR 1.58; CI: 1.10-2.26) vs none. We found no association between OC use to regulate periods or acne and MetS (OR 1.1; CI: 0.6-1.8). When adjusting for BMI, only the association of self-reported PCOS and MetS was attenuated (OR 1.78; CI: 0.92-3.44). CONCLUSIONS: In Hispanic/Latina women, irregular menstrual cycles, self-reported PCOS, and any PCOS sign were associated with MetS and could indicate women at metabolic disease risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Meyer ML, Sotres-Alvarez D, Steiner AZ, et al. Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study. J Clin Endocrinol Metab. 2020. PMID: 31917455. doi:10.1210/clinem/dgaa012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。